🇺🇸 FDA
Patent

US 7235577

Non-peptide inhibition of T-lymphocyte activation and therapies related thereto

granted A61KA61K31/065A61K31/16

Quick answer

US patent 7235577 (Non-peptide inhibition of T-lymphocyte activation and therapies related thereto) held by The Regents of the University of California expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/065, A61K31/16, A61K31/277, A61K31/40